User profiles for Annemarie M.C. van Rossum

Annemarie van Rossum

ErasmusMC Rotterdam
Verified email at erasmusmc.nl
Cited by 5542

Efficacy of highly active antiretroviral therapy in HIV-1 infected children

AMC van Rossum, PLA Fraaij… - The Lancet Infectious …, 2002 - thelancet.com
Although the reduction in HIV-1-related deaths with highly active antiretroviral therapy (HAART)
is similar in adults and children, the extent of the changes in two important surrogate …

Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis

…, P Brodin, S Uthaya, AMC van Rossum… - JAMA …, 2019 - jamanetwork.com
Importance The neonatal early-onset sepsis (EOS) calculator is a clinical risk stratification
tool increasingly used to guide the use of empirical antibiotics for newborns. Evidence on the …

Infection with and Carriage of Mycoplasma pneumoniae in Children

…, D Nadal, C Berger, C Vink, AMC van Rossum - Frontiers in …, 2016 - frontiersin.org
“Atypical” pneumonia was described as a distinct and mild form of community-acquired
pneumonia (CAP) already before Mycoplasma pneumoniae had been discovered and …

Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study

…, NG Hartwig, C Vink, AMC van Rossum - PLoS …, 2013 - journals.plos.org
Background Mycoplasma pneumoniae is thought to be a common cause of respiratory tract
infections (RTIs) in children. The diagnosis of M. pneumoniae RTIs currently relies on …

Host and Bacterial Factors Contributing to the Clearance of Colonization by Streptococcus pneumoniae in a Murine Model

AMC van Rossum, ES Lysenko… - Infection and …, 2005 - Am Soc Microbiol
Nasopharyngeal colonization is the first step in the interaction between Streptococcus
pneumoniae (the pneumococcus) and its human host. Factors that contribute to clearance of …

Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial …

…, EG Visser, SP Willemsen, AMC van Rossum… - The Lancet, 2017 - thelancet.com
Background Up to 7% of term and late-preterm neonates in high-income countries receive
antibiotics during the first 3 days of life because of suspected early-onset sepsis. The …

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth

G Verweel, AMC van Rossum, NG Hartwig… - …, 2002 - publications.aap.org
Introduction. Growth failure is a common feature of children with human immunodeficiency
virus type 1 (HIV-1) infection. Children who are treated with mono or dual nucleoside …

C-reactive protein, procalcitonin, and white blood count to rule out neonatal early-onset sepsis within 36 hours: a secondary analysis of the neonatal procalcitonin …

…, D Lehnick, AMC van Rossum - Clinical Infectious …, 2021 - academic.oup.com
Background Neonatal early-onset sepsis (EOS) is one of the main causes of global
neonatal mortality and morbidity, and initiation of early antibiotic treatment is key. However, …

Antibody Responses to Mycoplasma pneumoniae: Role in Pathogenesis and Diagnosis of Encephalitis?

…, E Jacobs, D Nadal, C Vink, AMC van Rossum - PLoS …, 2014 - journals.plos.org
The pathogenesis of encephalitis associated with the respiratory pathogen Mycoplasma
pneumoniae is not well understood. A direct infection of the central nervous system (CNS) and …

Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use

W Van Herk, M Stocker, AMC van Rossum - Journal of infection, 2016 - Elsevier
Early diagnosis and timely treatment of early onset neonatal sepsis (EOS) are essential to
prevent life threatening complications. Subtle, nonspecific clinical presentation and low …